Drug eluting stents for the treatment of bare metal in-stent restenosis: long-term outcomes in real world practice | Zendy

Clare Appleby | Zendy; Raj Khattar | Zendy; Kenneth Morgan | Zendy; Bernard Clarke | Zendy; Nick Curzen | Zendy; Ludwig Neyses | Zendy; Farzin FathOrdoubadi | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Drug eluting stents for the treatment of bare metal in-stent restenosis: long-term outcomes in real world practice

Author(s) -

Clare Appleby,

Raj Khattar,

Kenneth Morgan,

Bernard Clarke,

Nick Curzen,

Ludwig Neyses,

Farzin FathOrdoubadi

Publication year - 2011

Publication title -

eurointervention

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.592

H-Index - 78

eISSN - 1969-6213

pISSN - 1774-024X

DOI - 10.4244/eijv6i6a127

Subject(s) - medicine , mace , myocardial infarction , restenosis , cardiology , stent , cohort , bare metal stent , drug eluting stent , angioplasty , acute coronary syndrome , unstable angina , percutaneous coronary intervention , surgery

Drug eluting stents (DES) have had a great impact in reducing in-stent restenosis (ISR) in de novo lesions. However, long-term data regarding effectiveness and safety of these stents in treating bare metal stent (BMS) ISR are limited. We report long-term clinical outcomes in a cohort of patients with BMS-ISR treated with DES between April 2002 and December 2003 at our institution.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research